Delivery Order SPE2DB20D1109-SPE2DB25FP04K

Award Date 5/9/25
Potential Completion Date 5/12/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide 225 mg/1.5 ml Ajovy auto-injectable medication. The $1,421.20 contract has a performance period through March 7, 2024 and does not have a set-aside designation. This delivery order is issued under a larger indefinite delivery contract (IDC) valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,072.34 firm fixed price delivery order is for the supply of Ajovy 225 mg/1.5 ml autoinjector medication. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2020. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,086.71 firm-fixed-price contract is for the delivery of Ajovy 225 mg/1.5 ml autoinjector medication and has an ultimate completion date of August 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, to...
This federal contract award, valued at $1,231.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Ajovy, a 225 mg/1.5 ml syringe, with a completion date of May 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,657.95, is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product. The contract has a period of performance through February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,910.20 contract is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a specialty pharmaceutical product, with a completion date of February 21, 2024. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery...
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,847.18 to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ajovy 225 mg/1.5 ml autoinjector medication. The contract has a firm fixed price of $1,053.76 and a performance period ending on August 2, 2024. It is not a set-aside contract. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies for providing a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The $1,037.92 firm fixed price delivery order is for the supply of the pharmaceutical product AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, with a period of performance through April 3, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through...
This federal contract award to AmerisourceBergen Drug Corp is for the delivery of the pharmaceutical product AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML. The $1,852.60 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FP04K
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,199.10 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 225 mg/1.5 mL autoinjector doses of the drug Ajovy. The contract has a completion date of May 12, 2025 and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/8/25, 10:10 AM